Shouta Iwadou
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Randomized controlled study to examine the efficacy of hepatic arterial infusion chemotherapy with cisplatin before radiofrequency ablation for hepatocellular carcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 29, 2021
Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial.
Journal: Liver cancer
Published: August 09, 2019
Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib.
Journal: Journal of gastroenterology and hepatology
Published: August 16, 2018
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: January 02, 2018
Clinical characteristics and prognosis of non-B non-C hepatocellular carcinoma patients with modest alcohol consumption.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 02, 2015
Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma.
Journal: British journal of cancer
Published: April 27, 2013
Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma.
Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: February 28, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026